Cymabay Therapeutics Inc (NASDAQ:CBAY)

1.90
Delayed Data
As of May 17
 +0.11 / +6.15%
Today’s Change
1.67
Today|||52-Week Range
5.06
-43.79%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 11.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +478.95% increase from the last price of 1.90.

Chart unavailable

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Cymabay Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.64%
 
 
 
 
 
 
Growthannually 3.05%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.